Adenosine analogues for the treatment of the insulin resistance syndrome and diabetes
A Standard patent application filed on 14 May 2002 credited to Spade, Alfred P. ; Herling, Andreas ; Jahne, Gerhard ; Choi-sledeski, Yong-Mi ; Maguire, Martin P. ; Myers, Michael R. ; Ewing, William R. ; Pauls, Henry W.

Details

Application number :

2002342317  

Application type :

Standard  

Application status :

LAPSED  

Under opposition :

No  

Proceeding type :

 

Invention title :

Adenosine analogues for the treatment of the insulin resistance syndrome and diabetes  

Inventor :

Spade, Alfred P. ; Herling, Andreas ; Jahne, Gerhard ; Choi-sledeski, Yong-Mi ; Maguire, Martin P. ; Myers, Michael R. ; Ewing, William R. ; Pauls, Henry W.  

Agent name :

Watermark Patent and Trade Marks Attorneys  

Address for service :

Level 2 302 Burwood Road Hawthorn VIC 3122 Australia  

Filing date :

14 May 2002  

Associated companies :

 

Applicant name :

Sanofi-Aventis Deutschland GmbH  

Applicant address :

Bruningstrasse 50 65929 Frankfurt am Main Germany  

Old name :

Aventis Pharma Deutschland GmbH  

Original Source :

Go